glp-1 for mash Semaglutide targets molecular pathways beyond weight loss Novo's Wegovy becomes first GLP-1

Prescribing information approved by the MHRA specifies dosing frequency but generally allows flexibility regarding time of day for once-weekly and once-daily formulations

The prototype drug could not be detected 4 h after administration, and its elimination half-life was less than 30 min

Mitochondrial Longevity Mitochondrial GSH (mGSH) is independently regulated from cytosolic pools and is the primary defence against mitochondrial lipid peroxidation and protein oxidation

Combination therapy with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors in older patients with type 2 diabetes: A real-world evidence study

Some required gallbladder removal surgery (cholecystectomy)